Company patents
Cellectis
Cellectis's patent strategy is heavily concentrated in pharma_biotech, with Pharmaceutical Preparations (66.2% of portfolio) and Peptides & Proteins (59.5%) being dominant. Surprisingly, despite this focus, patenting activity in these core areas has seen significant year-over-year declines in 2025 and so far in 2026, with Pharmaceutical Preparations dropping by 31.6% and 61.5% respectively, and Peptides & Proteins by 37.5% and 50.0%, suggesting a potential shift in their R&D or IP protection priorities within their established strengths.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
74 US filings (since 2023) · 7 categories · 9 themes
Development of therapeutic approaches involving the genetic modification of cells (e.g., T cells, stem cells, macrophages) or the use of viral/non-viral vectors to deliver genetic material for disease treatment.
Therapeutic approaches involving the use of living cells, often genetically modified or ex vivo activated, to treat diseases, particularly cancer, by modulating immune responses or replacing damaged cells.
Design and modification of antibodies or antibody-derived fragments for targeted therapeutic intervention, including bispecific formats, Fc region modifications, and activatable constructs.
Design and engineering of proteins or peptides to directly modulate immune responses, including enhancing antigen presentation, suppressing inflammation, or activating specific immune cell types.
Therapeutic strategies employing nucleic acids (DNA, RNA, oligonucleotides) to modulate gene expression, deliver genetic material, or interfere with disease-causing pathways. Includes gene therapy using viral vectors.
Methods and compositions for introducing, modifying, or expressing foreign genetic material within plant cells to confer new traits, produce novel compounds, or enhance existing characteristics.
Engineering or breeding plants to exhibit enhanced resistance or tolerance to pathogens (fungi, bacteria, viruses) or pests, often involving the identification and introduction of specific resistance genes or genomic regions.
Development and characterization of novel plant varieties or cultivars, including field crops, vegetables, fruits, and ornamental plants, focusing on improved agronomic performance, aesthetic qualities, or specific product characteristics.
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Patents
Showing 101-110 of 114